Association of Hematological Changes and Recurrence Status among Colorectal Cancer Patients in a Tertiary Referral Hospital

Read full text Summarise with VIRAT
Authors: Muhammad Yakub Adira Putra, Safruddin Nasution
Cited by: 0
References: 12

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Background: Colorectal cancer (CRC) remains one of the leading causes of cancer-related morbidity and mortality worldwide. Systemic inflammation is known to influence tumor progression and recurrence. Hematological parameters derived from routine complete blood count (CBC), such as hemoglobin level, leukocyte count, platelet count, and inflammatory indices including neutrophil-to-lymphocyte ratio (NLR) and platelet-to-lymphocyte ratio (PLR), may reflect tumor–host interactions and have potential prognostic value. This study aimed to evaluate the association between hematological changes and recurrence status among colorectal cancer patients treated in a tertiary referral hospital. Methods: This observational analytical study used a cross-sectional design based on secondary data from medical records of colorectal cancer patients treated between January 2020 and December 2024 in a tertiary referral hospital in Indonesia. Patients aged ≥18 years with histopathologically confirmed colorectal cancer and available preoperative CBC results were included. Hematological parameters analyzed included hemoglobin, leukocyte count, platelet count, neutrophil count, lymphocyte count, NLR, and PLR. Hematological abnormalities were categorized as presence or absence of hematological changes. Disease-free survival status was classified into recurrence and no recurrence. Statistical analysis was performed using the Fisher exact test with a significance level of p < 0.05. Results: A total of 32 patients were included with a mean age of 56.4 ± 11.2 years; 62.5% were male. The mean hemoglobin level was 12.7 ± 2.2 g/dL, leukocyte count 8.3 ± 2.1 ×10³/µL, platelet count 320.6 ± 128.4 ×10³/µL, NLR 3.1 ± 1.6, and PLR 189.4 ± 92.7. During follow-up, 18 patients (56.3%) remained disease-free and 14 patients (43.7%) developed recurrence. Hematological changes were observed in 19 patients (59.4%) and were significantly associated with recurrence status (p = 0.028). Conclusion: Hematological changes derived from routine CBC parameters were significantly associated with recurrence status in colorectal cancer patients. These parameters may serve as accessible indicators for identifying patients at risk of recurrence, although further studies with larger cohorts are needed to confirm their prognostic value.

Fields of Study & Subjects

Inflammatory Biomarkers in Disease Prognosis Colorectal Cancer Treatments and Studies Cancer Stress Anesthesia and Immune Response

Publication details

Journal / source
International Journal of Research Publications
Volume
192
Issue
1
Publication date
16 February 2026
Language
EN